FDA Brief

Warning letters Drugs

FDA warning letter to

Centaur Pharmaceuticals Private Ltd.

Issued Jun 5, 2023Posted Jul 18, 2023Center for Drug Evaluation and Research | CDER

CGMP/Active Pharmaceutical Ingredient (API)/Adulterated. We haven't summarized this letter yet. Read it on fda.gov.

Centaur Pharmaceuticals Private Ltd.'s FDA history

  1. Centaur Pharmaceuticals Private Ltd.

    CGMP/Finished Pharmaceuticals/Adulterated

Full company page